Although the pathogenesis of EMPD remains poorly understood, its immunohistochemical profile reportedly resembles that of breast cancer, particularly in terms of human epidermal growth factor receptor 2 (HER2) expression. The gene discussed is ERBB2; the disease is breast cancer.